Who owns CNS PHARMACEUTICALS INC?
- CUSIP Number: 18978h201
Tip: Access positions for across all investors
Analyze quarterly positions in Cns Pharmaceuticals with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Cns Pharmaceuticals stock
Who bought or sold CNS PHARMACEUTICALS INC this quarter?
There are no current stakeholders of Cns Pharmaceuticals.
This is normal when the security:
- Has been acquired or taken private
- Has merged with another entity
- Has changed its name and has a new CUSIP (and/or symbol)
- Has been delisted and the ticker has changed
Please use Search to find the security you were looking for.
Who sold out of Cns Pharmaceuticals?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Armistice Capital | Mar 2024 | 471k | $171k |
| Virtu Financial | Mar 2024 | 94k | $34k |
| Citadel Advisors | Mar 2024 | 91k | $33k |
| Vanguard Group | Mar 2024 | 58k | $21k |
| Geode Capital Management | Mar 2024 | 28k | $10k |
| Jane Street | Mar 2024 | 27k | $9.9k |
| State Street Corporation | Mar 2024 | 23k | $8.2k |
| Hrt Financial | Mar 2024 | 22k | $7.0k |
| Two Sigma Securities | Mar 2024 | 22k | $7.9k |
| XTX Topco | Mar 2024 | 19k | $6.8k |
| Tower Research Capital | Mar 2024 | 6.8k | $2.5k |
| Bank of America Corporation | Mar 2024 | 779.00 | $0 |
| Wells Fargo & Company | Mar 2024 | 241.00 | $87.627600 |
| Morgan Stanley | Mar 2024 | 67.00 | $23.999400 |